SCHEDULE 13G/A

CIDARA THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 171757206

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BIOTECHNOLOGY VALUE FUND L P

  Shares: 729,856.00 · Class: 2.7%

• BVF I GP LLC

  Shares: 729,856.00 · Class: 2.7%

• BIOTECHNOLOGY VALUE FUND II LP

  Shares: 578,633.00 · Class: 2.1%

• BVF II GP LLC

  Shares: 578,633.00 · Class: 2.1%

• Biotechnology Value Trading Fund OS LP

  Shares: 77,407.00 · Class: 0.3%

• BVF Partners OS Ltd.

  Shares: 77,407.00 · Class: 0.3%

• BVF GP HOLDINGS LLC

  Shares: 1,308,489.00 · Class: 4.8%

• BVF PARTNERS L P/IL

  Shares: 1,414,165.00 · Class: 5.2%

• BVF INC/IL

  Shares: 1,414,165.00 · Class: 5.2%

• LAMPERT MARK N

  Shares: 1,414,165.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.